Novartis to buy Regulus Therapeutics for as much as $1.7 billion
- Posted on May 2, 2025
- By Los Angeles Times
- 1 Views
Novartis to buy Regulus Therapeutics for as much as $1.7 billion
Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion.
